
Keywords: ACEI; angiotensin-converting enzyme inhibitor; PDC; proportion of days covered; CI; confidence interval; AHR; adjusted hazard ratios; Cardiovascular disease; Respiratory disease; Angiotensin-converting enzyme inhibitor; Lisinopril; Perindopril; Hospital a